(NASDAQ: NOTV) Inotiv's forecast annual revenue growth rate of 5.5% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.7%.
Inotiv's revenue in 2025 is $475,114,000.On average, 1 Wall Street analysts forecast NOTV's revenue for 2025 to be $16,865,202,499, with the lowest NOTV revenue forecast at $16,865,202,499, and the highest NOTV revenue forecast at $16,865,202,499. On average, 1 Wall Street analysts forecast NOTV's revenue for 2026 to be $17,889,070,500, with the lowest NOTV revenue forecast at $17,889,070,500, and the highest NOTV revenue forecast at $17,889,070,500.
In 2027, NOTV is forecast to generate $18,978,644,884 in revenue, with the lowest revenue forecast at $18,978,644,884 and the highest revenue forecast at $18,978,644,884.